Deflin Gayle
- SEC CIK
- 0001866024
No open-market purchases or sales filed in the past year.
Current role at each company
- AMPH Amphastar Pharmaceuticals, Inc.Directoras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Deflin Gayle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 (view filing) | Nov 14 | 1 day | Deflin GayleDirector | SSale | −4.16K | $55.45 | −$230.8K | −60.5%2.72K after | |
| May 19, 2023 (view filing) | May 18 | 1 day | Deflin GayleDirector | SSale | −4.52K | $44.01 | −$198.9K | −52.1%4.16K after | |
| May 17, 2023 (view filing) | May 15 | 2 days | Deflin GayleDirector | SSale | −1.50K | $43.15 | −$64.7K | −14.7%8.68K after |